openPR Logo
Press release

Global Subcutaneous Injection Ports Market Analysis Covers Challenges, Demand , Growth, Trends, and Forecast Till 2026 || Key Participants- Medtronic MiniMed Inc., Applied Medical Technology Ltd, Unomedical a/s

10-05-2018 03:12 PM CET | Health & Medicine

Press release from: Fact.MR

Global Subcutaneous Injection Ports Market Analysis Covers

This research report titled “Subcutaneous Injection Ports Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2026” focuses on the Subcutaneous Injection Ports Market, published to the vast repository managed by Fact. MR.  The analysis focuses on the prime geographical regions based on their market size, revenue and attractiveness factors. Furthermore, the research discusses various segments from the Subcutaneous Injection Ports Marke to examine future lucrativeness and spot growth prospects during the period “between” 2018-2026.  Readers can even access information such as key developments, technologies, innovations, etc., concerned to the Subcutaneous Injection Ports Market.

Request Customization of this Report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=876

Subcutaneous injection is considered a standard method for the delivery of medication into a patient’s body. To facilitate subcutaneous injection, subcutaneous injection ports are used. Subcutaneous injection ports are sterile medication delivery device. Subcutaneous injection ports consists of a silicone injection membrane on a hard base. Through subcutaneous injection port physician prescribed medications can be directly injected into the subcutaneous tissue using a standard needle and syringe, an injection pen, or other manual injection device. Subcutaneous injection port is a device that cannot be used with an injection pump.

Furthermore, subcutaneous injection ports are also used for multiple subcutaneous injections for a period of up to 72 hours. Subcutaneous injection port avoids the repeated needle punctures of the skin. This device is widely used for patients who require prolonged central venous access. A subcutaneous injection port is generally a disposable device usually inserted into the skin for a period of up to 5 days. Insulin is injected through a syringe into subcutaneous injection port. Medicines are directly injected through the resealable septum at the top of the device. The needle of the syringe is placed above the surface of the skin whereas the medication is delivered through the soft cannula. A subcutaneous injection port consists of a build in inserter, which give users a virtually painless application.  A subcutaneous injection port is usually used with an intrathecal or epidural catheter. Subcutaneous injection ports have low infection rate, but require suitable expertise for their insertion.

The global subcutaneous injection ports market is expected to witness a significant growth over the forecast period due to rising prevalence of cancer and diabetes across the globe. Increasing investment of manufacturers in the development of subcutaneous injection port is further driving the growth of the global subcutaneous injection ports market. Furthermore, over the past decade, more patient-friendly devices have enhanced the demand for subcutaneous injection ports. However, lack of focus on health expenditure, declining reimbursements and others factors are the hindrance of the global subcutaneous injection ports market.

The global market for subcutaneous injection port is segmented on basis of product type, end user and geography.

Based on Product Type, the global subcutaneous injection ports market is segmented into:
I-Port
Insuflon
Based on End User, the global subcutaneous injection ports market is segmented into:
Hospitals
Clinics
Home Care Settings
On the basis of geography, the global subcutaneous injection ports market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and the Middle East & Africa. North America will continue to dominate the global subcutaneous injection ports market due to the availability of advanced technologies. Europe is expected to hold the second large market share in the global subcutaneous injection ports market. Asia Pacific is also one of the fast-growing regions in the global subcutaneous injection ports market due to high incidence of diabetes in low-income countries. Moreover, the Middle East and Africa and Latin America are expected to show slow growth in the global subcutaneous injection ports market due to delayed introduction of the product in these regions.

To get complete report about Subcutaneous Injection Ports Market, Visit: https://www.factmr.com/report/876/subcutaneous-injection-ports-market

Examples of some of the key players present in the global subcutaneous injection ports market are Medtronic MiniMed, Inc., Applied Medical Technology Ltd, Unomedical a/s and others.

The report covers exhaustive analysis on:

Subcutaneous Injection Ports Market Segments
Subcutaneous Injection Ports Market Dynamics
Historical Actual Market Size, 2013 - 2017
Subcutaneous Injection Ports Market Size & Forecast 2018 to 2026
Subcutaneous Injection Ports Market Current Trends/Issues/Challenges
Competition & Companies involved
Subcutaneous Injection Ports Market Drivers and Restraints
Regional analysis includes

North America
Latin America
Europe
Asia Pacific excluding China
China
Middle East & Africa
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

For Further Insights and Segment-Specific Information, Contact a Market Analyst at: https://www.factmr.com/connectus/sample?flag=AE&rep_id=876

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Subcutaneous Injection Ports Market Analysis Covers Challenges, Demand , Growth, Trends, and Forecast Till 2026 || Key Participants- Medtronic MiniMed Inc., Applied Medical Technology Ltd, Unomedical a/s here

News-ID: 1284130 • Views:

More Releases from Fact.MR

Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
The global Allyl Polyether Market (アリルポリエーテル市場) was valued at approximately US$ 63.8 million in 2023 and is projected to reach around US$ 99.1 million by the end of 2033, growing at a compound annual growth rate (CAGR) of 4.5%. The Allyl Polyether Market is a segment of the polymer industry that has been witnessing steady growth in recent years. This growth can be attributed to several factors, including the increasing demand
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
The global Construction Aggregate Market (建設骨材市場) is poised to reach US$ 418.14 billion by 2024, with a projected Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2034. The surge in global population has fueled construction activities, leading to a substantial demand for construction aggregates. Moreover, governments in developing nations are heavily investing in infrastructure development, further boosting the demand for construction aggregates. The launch of numerous mega projects
Chromatography Syringes Market to Experience Notable Growth by 2032
04-17-2024 | Health & Medicine
Fact.MR
Chromatography Syringes Market to Experience Notable Growth by 2032
The market research and competitive intelligence company Fact.MR recently released a report estimating that sales of Chromatography Syringes would reach a valuation of US$ 140 million by 2032, growing at a compound annual growth rate (CAGR) of roughly 6% between 2022 and 2032. Developments in chromatography syringe design and calibration, such as digitalization leading to appropriate sample pooling, are improving the performance of chromatography columns. These advancements offer benefits such faster
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from 2022 to 2032
04-17-2024 | Health & Medicine
Fact.MR
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from …
It is projected that the worldwide market for Sacroiliac Joint Fusion would be valued US$ 3,900 million by 2032, up from US$ 620 million in 2022. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032. the rapid technological advancement in the healthcare industry and the growing demand for minimally invasive surgical treatments are responsible for the market's progress. orthopedic doctors at Yale Medicine frequently

All 5 Releases


More Releases for Subcutaneous

Growth Opportunities in the Global Subcutaneous Biologics Market
Increase in Awareness and the number of Diagnosed cases will Drive Demand in Developing Regions In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for
Subcutaneous Injector Sales Market Report 2017
Subcutaneous Injector market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Browse the full report with a table of contents : https://www.reportsandmarkets.com/reports/global-subcutaneous-injector-sales-market-report-2017-1701051 Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Subcutaneous Injector for
Unmet Need Remains for Subcutaneous Sustained Release Injectables
(Amherst, NH) - As patients live longer and the prevalence and incidence of chronic ailments increase across the general population, drug developers and their delivery device partners are adapting to address what will become a significant market opportunity. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration and reduced dosing frequency. With the shift away from caregiver interaction, drug safety and compliance/adherence
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Global Subcutaneous Immunoglobulin Market: Overview Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are
Subcutaneous Immunoglobulin Market Demand and Growth Upto 2024
Immunoglobulin, commonly known as an antibody, is a Y-shaped protein manufactured primarily by plasma cells. Immunoglobulin is utilized by the immune system to counterbalance pathogens. Subcutaneous injections are administered as vaccines and medications including insulin and immunoglobulin. The process of administering immunoglobulin is known as immunoglobulin therapy. When immunoglobulin therapy is applied below the dermis and epidermis, or cutis, it is known as subcutaneous immunoglobulin. Subcutaneous therapy is useful as
Subcutaneous Drug Delivery Market & Pipeline Insight
Subcutaneous sites along with intramuscular and intravenous sites are part of parenteral route of drug entry. Maximum pharmacological benefits of a drug could be achieved by deciding effective route of administration depending upon pharmacodynamic properties of the drug to be used. Subcutaneous route is commonly used for the administration of therapeutics into the body for better drug delivery of lipophilic, proteinecious, small molecule drugs. It is characterized by less vasculature,